The impact of non-medical switching among ambulatory patients: an updated systematic literature review-Reference-Cited by-同舟云学术

The impact of non-medical switching among ambulatory patients: an updated systematic literature review

Published:2019-01-01 Issue:1 Volume:7 Page:1678563
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Weeda Erin R.¹^ORCID,Nguyen Elaine²,Martin Silas³,Ingham Michael³,Sobieraj Diana M.⁴,Bookhart Brahim K.³,Coleman Craig I.⁴

Affiliation:

1. The College of Pharmacy, Medical University of South Carolina, Charleston, SC, USA

2. Department of Pharmacy Practice, Idaho State University College of Pharmacy, Boise, ID, USA

3. Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, USA

4. University of Connecticut School of Pharmacy, Storrs, CT, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2019.1678563

Reference58 articles.

1. Guidelines for Therapeutic Interchange—2004

2. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review

3. Prior Authorization and Utilization Management Reform Principles. American Medical Association. 2017 [cited 2018 Nov 10]. Available from: https://www.ama-assn.org/sites/default/files/media-browser/principles-with-signatory-page-for-slsc.pdf

4. Non-Medical Switching of Medications in Select States. Connecticut general assembly. Office of legislative research. 2017 [cited 2018 Nov 10]. Available from: https://www.cga.ct.gov/2017/rpt/pdf/2017-R-0201.pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?;Journal of Health Economics and Outcomes Research;2024-03-25

2. Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?;Journal of Health Economics and Outcomes Research;2024-03-25

3. Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region;BioDrugs;2024-02-25

4. Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?;2023-11-07

5. Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review;Advances in Therapy;2023-09-19